Manufacturer record
Medipol Pharmaceuticals India Pvt. Ltd. 1199/3: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Medipol Pharmaceuticals India Pvt. Ltd. 1199/3 (Himachal Pradesh) were declared Not of Standard Quality between April 2020 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: IBS-022, Ibuprofen Oral Suspension BP 100 mg/5ml (exp Jun 2026). DTL Baddi Distt. Solan (state lab) found it not of standard quality: The sample does not conform to claim as per BP 2024 in respect to the Assay of Ibuprofen. Listed in the May 2025 alert.
Records by type
5 records linked to Medipol Pharmaceuticals India Pvt. Ltd. 1199/3 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ibuprofen Oral Suspension BP 100 mg/5ml | Batch IBS-022Mfg Jul 2024 · Exp Jun 2026 | The sample does not conform to claim as per BP 2024 in respect to the Assay of IbuprofenAssay | DTL Baddi Distt. SolanState lab | May 2025 |
| Ferrous Sulphate & Folic Acid Syrup IP | Batch FSF-158Mfg Oct 2024 · Exp Sep 2026 | The sample does not conform to claim as per IP 2022 in respect to the Test of Free Ferric Compounds & Assay of Folic AcidAssay | DTL Baddi Distt. SolanState lab | May 2025 |
| Montelukast Sodium & Levocetirizine Hydrochloride Tablets I.P. | Batch TMNL-018Mfg Jan 2019 · Exp Dec 2020 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2020 |
| Montelukast Sodium & Levocetirizine Hydrochloride Tablets I.P. | Batch TMNL-018Mfg Jan 2019 · Exp Dec 2020 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2020 |
| Levocetirizine & Montelukast Tablets I.P. | Batch TMNL-008Mfg Dec 2018 · Exp Nov 2020 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.